Vol 11, No 6 (2006)
Original papers
Published online: 2006-01-01

open access

Page views 146
Article views/downloads 176
Get Citation

Connect on Social Media

Connect on Social Media

Long-term changes of prostacyclin secretion in radiation-induced myelopathy

Seied Rabie Mahdavi1, Alireza Shirazi2, Bagher Minaee3, Alireza Nikoofar4, Hamid Reza Mirzaee5
DOI: 10.1016/S1507-1367(06)71072-0
Rep Pract Oncol Radiother 2006;11(6):273-279.

Abstract

Background

We have previously reported the short-term changes in prostacyclin profile after irradiation of rat cervical cord.

Aim

Present research investigated the long-term changes of prostacyclin content.

Materials/Methods

Wistar rats in groups of five were irradiated with doses of 2, 4, 6, 15, 25, 30 Gy and a single group of 25 with 35 Gy X-rays. After 26 and 39 weeks, prostacyclin content was quantified by 6-keto-prostaglandin-F1α (prostacyclin stabilized metabolite). Specimens were stained routinely for histological studies.

Results

The 50% latent period and effective dose were 14.86±1.16 weeks and 25.66±0.54 Gy (p<0.0001), respectively. Average ratios of 6-keto-PG-F1α for doses of 2–30 Gy were between 78.33–12.93% and 79.48–99.96% for 26 and 39 weeks, respectively. Prostacyclin level after 35 Gy shows approximately a 7:1 ratio in comparison to the control group (p<0.002). Histopathological changes in glial and vascular tissues were diagnosed and scored. Prostacyclin bimodal profile was observed.

Conclusions

Radiation can cause complex fluctuations of prostacyclin in association with marked histopathological changes.

Article available in PDF format

View PDF Download PDF file



Reports of Practical Oncology and Radiotherapy